A Plus Biotechnology , Ltd. Current Cash

The latest current cash for 6918.TWO is $610M as of March 2026. That compares with $410M in the prior-year period — up 49.3% year over year. Investors often review this figure alongside A Plus Biotechnology , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 6918.TWO's current cash moved from $410M to $610M — a 49.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in A Plus Biotechnology , Ltd.'s operating scale or balance-sheet position.

A current cash figure of $610M for 6918.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 6918.TWO's current cash ($610M), review year-over-year change from $410M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.